The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
α4β2 Nicotinic Receptors with High and Low Acetylcholine Sensitivity: Pharmacology, Stoichiometry, and Sensitivity to Long-Term Exposure to Nicotine
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and gating mechanism of the acetylcholine receptor pore
Miyazawa, A., Fujiyoshi, Y., & Unwin, N. (2003) · Nature · doi:10.1038/nature01748 · Cited by 1,270
Nicotinic Receptors at the Amino Acid Level
Corringer, P.-J., Novère, N. L., & Changeux, J.-P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.431 · Cited by 820
Nicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. (2004) · Science · doi:10.1126/science.1099420 · Cited by 686
The benzodiazepine binding site of GABAA receptors
Sigel, E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01118-8 · Cited by 594
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566 · cited 2×
“, 2002), and they play a direct role in nicotine addiction (Picciotto et al., 2001; Tapper et al., 2004; Maskos et al., 2005).”
BackgroundMutations in the channel domain alter desensitization of a neuronal nicotinic receptor
Revah, F., Bertrand, D., Galzi, J.-L., Devillers-Thiéry, A., Mulle, C., Hussy, N., Bertrand, S., Ballivet, M., & Changeux, J.-P. (1991) · Nature · doi:10.1038/353846a0 · Cited by 525
Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor
Cooper, E., Couturier, S., & Ballivet, M. (1991) · Nature · doi:10.1038/350235a0 · Cited by 469
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422
Chavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · PubMed · Cited by 392
Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function
Buisson, B., & Bertrand, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01819.2001 · Cited by 361
Anand, R., Conroy, W. G., Schoepfer, R., Whiting, P., & Lindstrom, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99147-7 · Cited by 315
Labarca, C., Nowak, M. W., Zhang, H., Tang, L., Deshpande, P., & Lester, H. A. (1995) · Nature · doi:10.1038/376514a0 · Cited by 302
The benzodiazepine binding site of GABAA receptors
Sigel, E., & Buhr, A. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90675-1 · Cited by 290
Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors
Kuryatov, A., Luo, J., Cooper, J., & Lindstrom, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012419 · Cited by 275
Nicotine upregulates its own receptors through enhanced intracellular maturation
Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., & Corringer, P. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.029 · Cited by 261
Genetic manipulation of ion channels: A new approach to structure and mechanism
Miller, C. (1989) · Neuron · doi:10.1016/0896-6273(89)90304-8 · Cited by 223
Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00161-9 · Cited by 221
Zwart, R., & Vijverberg, H. P. M. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1124 · Cited by 215
Self-citationChavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36376-1 · Cited by 207
Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism
Vallejo, Y. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5240-04.2005 · Cited by 201
Nashmi, R., Dickinson, M. E., McKinney, S., Jareb, M., Labarca, C., Fraser, S. E., & Lester, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11554.2003 · Cited by 188
Wang, F., Nelson, M. E., Kuryatov, A., Olale, F., Cooper, J., Keyser, K., & Lindstrom, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28721 · Cited by 187
Sine, S. M., & Taylor, P. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69047-2 · Cited by 158
Chang, Y., & Weiss, D. S. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77089-x · Cited by 137
Marks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J., & Collins, A. C. (1999) · PubMed · Cited by 126
Neuronal nicotinic acetylcholine receptors: from the gene to the disease
Weiland, S., Bertrand, D., & Leonard, S. S. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00199-6 · Cited by 126
Stoichiometry of the α9α10 Nicotinic Cholinergic Receptor
Plazas, P. V., Katz, E., Gómez‐Casati, M. E., Bouzat, C., & Elgoyhen, A. B. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3805-05.2005 · Cited by 104
Hales, T. G., Dunlop, J. I., Deeb, T. Z., Carland, J. E., Kelley, S. P., Lambert, J. J., & Peters, J. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513222200 · Cited by 95
Miledi, R., Eusebi, F., Martínez‐Torres, A., Palma, E., & Trettel, F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192445299 · Cited by 91
Corringer, P.-J., Sallette, J., & Changeux, J.-P. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.012 · Cited by 86 · cited 2×
“We were surprised to find that maximal [3H]cytisine binding to oocytes injected with a 10:1 4/ 2 cDNA ratio was not increased by nicotine, which should have occurred if nicotine enhanced intracellular receptor maturation (Kuryatov et al., 2005; Sallette et al., 2005; Corringer et al., 2006).”
BackgroundBoorman, J. P., Groot‐Kormelink, P. J., & Sivilotti, L. G. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00565.x · Cited by 83
From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research
Cassels, B. K., Bermúdez, I., Dajas, F., Abin‐Carriquiry, J. A., & Wonnacott, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03665-2 · Cited by 81
Self-citationMarks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J.-P., & Collins, A. C. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38240-0 · Cited by 79
Nicotine and neurodegeneration in ageing
Zanardi, A., Leo, G., Biagini, G., & Zoli, M. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00502-1 · Cited by 70
López‐Hernández, G. Y., Sánchez-Padilla, J., Ortiz‐Acevedo, A., Lizardi-Ortiz, J. E., Salas-Vincenty, J., Rojas, L. V., & Lasalde‐Dominicci, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403537200 · Cited by 59
Palma, E., Trettel, F., Fucile, S., Renzi, M., Miledi, R., & Eusebi, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438006100 · Cited by 57
Rush, R., Kuryatov, A., Nelson, M. E., & Lindstrom, J. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.6.1416 · Cited by 40
5-I A-85380 and TC-2559 differentially activate heterologously expressed α4β2 nicotinic receptors
Zwart, R., Broad, L. M., Xi, Q., Lee, M. W., Moroni, M., Bermúdez, I., & Sher, E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.077 · Cited by 38
Self-citationBriggs, C. A., Gubbins, E. J., Marks, M. J., Putman, C. B., Thimmapaya, R., Meyer, M. D., & Surowy, C. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020198 · Cited by 33
Palma, E., Fucile, S., Barabino, B., Miledi, R., & Eusebi, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13421 · Cited by 26
Butt, C. M., Hutton, S. R., Marks, M. J., & Collins, A. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01135.x · Cited by 23
Li, J., Flotildes, K., Li, M., & Cohen, B. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01578.x · Cited by 19
Cited by
Structural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469
Diversity of vertebrate nicotinic acetylcholine receptors
Millar, N. S., & Gotti, C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.041 · Cited by 441
Nicotine binding to brain receptors requires a strong cation–π interaction
Xiu, X., Puskar, N. L., Shanata, J. A. P., Lester, H. A., & Dougherty, D. A. (2009) · Nature · doi:10.1038/nature07768 · Cited by 363
Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338
The structural basis of function in Cys-loop receptors
Thompson, A. J., Lester, H. A., & Lummis, S. C. R. (2010) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583510000168 · Cited by 341
Metadata
- Authors
- Moroni, M., Zwart, R., Sher, E., Cassels, B. K., & Bermudez, I.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 70
- Issue
- 2
- Pages
- 755-768
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2092364608
- Cited by
- 287
- References
- 42
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.